A Study of PHN-012 in Patients With Advanced Solid Tumors
Pheon Therapeutics
Pheon Therapeutics
Kivu Bioscience Inc.
Boehringer Ingelheim
AbbVie
Travera Inc
Eli Lilly and Company
Nammi Therapeutics Inc
Bristol-Myers Squibb
Jazz Pharmaceuticals
Revolution Medicines, Inc.
AstraZeneca
Seagen Inc.
Seagen Inc.
Pfizer
Actuate Therapeutics Inc.
Alterome Therapeutics, Inc.
Verastem, Inc.
EMD Serono
AstraZeneca
Eli Lilly and Company
RasCal Therapeutics, Inc.
Frontier Medicines Corporation
Filamon LTD
Origin Sciences
Eli Lilly and Company
NeoImmuneTech
Hoffmann-La Roche
ViroMissile, Inc.
Erasca, Inc.
A2 Biotherapeutics Inc.
AstraZeneca
Arvinas Inc.
Tasca Therapeutics
MBrace Therapeutics
A2 Biotherapeutics Inc.
Revolution Medicines, Inc.
Poseida Therapeutics, Inc.
MacroGenics
Revolution Medicines, Inc.
Auricula Biosciences Inc.
xCures
Daiichi Sankyo
SN BioScience
Takeda
Boehringer Ingelheim
EXoPERT
Adela, Inc
Natera, Inc.
Second Life Therapeutics
Eli Lilly and Company